Should we look for silent XXXX in @entity1 with @entity1150 ?

@entity1 @entity4620 @entity1151 @entity1150 @entity887 @entity715 @entity11942
BACKGROUND: Asymptomatic or silent @entity1151 (S-PE) in @entity1 with @entity1150 has been the focus of numerous publications with the objective of determining the incidence of S-PE and assessing whether its existence has any clinical or therapeutic consequences that outweigh the risks associated with the diagnostic tests performed and the increased healthcare costs. The objectives were to assess the incidence of S-PE using computed tomography angiogram (CTA), to understand the epidemiological factors that might trigger @entity887 , and to assess whether @entity4620 ( @entity4620 ) predicts the existence of S-PE's. METHODS: A prospective and consecutive assessment of 103 hospitalized @entity1 with lower limb @entity11942 in the absence of PE symptoms, using CT scan. @entity4620 was quantified before anticoagulation. The risk factors and characteristics of the @entity11942 were studied. A three-year follow-up assessing risk recurrence and clinical outcome was performed. RESULTS: The incidence of S-PE was 66%. In 77% of these cases, the main and lobar pulmonary arteries were affected. Iliac and femoral DVTs most often produced S-PE. ROC curve with a @entity4620 value higher than 578  ng/ml provided good sensitivity but low specificity to identify @entity1 with S-PE. Diagnosis entailed higher hospitalization expenses. No significant recurrence rate of @entity715 events was observed in the S-PE group during the follow-up. CONCLUSIONS: The incidence of S-PE in lower-limb @entity11942 is high, but in the absence of symptoms, diagnosis does not appear to be necessary, as there are no short- or long-term clinical or therapeutic consequences.
